tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
PremiumRatingsImmunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
8d ago
Immunocore assumed with a Neutral at Guggenheim
Premium
The Fly
Immunocore assumed with a Neutral at Guggenheim
1M ago
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
Premium
Company Announcements
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
3M ago
Immunocore reports Q2 EPS (20c), consensus (21c)
PremiumThe FlyImmunocore reports Q2 EPS (20c), consensus (21c)
3M ago
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
Premium
Ratings
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
5M ago
AMD, Block upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD, Block upgraded: Wall Street’s top analyst calls
5M ago
Immunocore price target lowered to $52 from $66 at Barclays
PremiumThe FlyImmunocore price target lowered to $52 from $66 at Barclays
6M ago
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
Premium
Ratings
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
6M ago
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
Premium
Ratings
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100